Seres Therapeutics, Inc. — All Filings
682 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
EFFECT
FWP
POS AM
POSASR
PRE 14A
PREM14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 SUBMISSION | 0000899243-22-024004 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-024008 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-024010 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-023979 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-024013 | Jun 24, 2022 | Jun 22, 2022 |
| 8-K | 8-K | 0001193125-22-181465 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-023972 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-023973 | Jun 24, 2022 | Jun 22, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-023974 | Jun 24, 2022 | Jun 22, 2022 |
| 8-K | 8-K | 0001193125-22-168845 | Jun 7, 2022 | — |
| EFFECT | — | 9999999995-22-001340 | May 6, 2022 | — |
| POS AM | POS AM | 0001193125-22-140444 | May 4, 2022 | — |
| 8-K | 8-K | 0001193125-22-139450 | May 4, 2022 | — |
| 10-Q | 10-Q | 0000950170-22-007217 | May 4, 2022 | Mar 31, 2022 |
| DEF 14A | DEF 14A | 0001193125-22-133526 | Apr 29, 2022 | Jun 22, 2022 |
| DEFA14A | DEFA14A | 0001193125-22-133624 | Apr 29, 2022 | — |
| 8-K | 8-K | 0001193125-22-096755 | Apr 6, 2022 | — |
| POS AM | POS AM | 0001193125-22-060382 | Mar 1, 2022 | — |
| 10-K | 10-K | 0000950170-22-002435 | Mar 1, 2022 | Dec 31, 2021 |
| S-8 | S-8 | 0001193125-22-060244 | Mar 1, 2022 | — |
| 8-K | 8-K | 0001193125-22-059784 | Mar 1, 2022 | — |
| POSASR | POSASR | 0001193125-22-060153 | Mar 1, 2022 | — |
| SC 13G/A | SC13G/A | 0001140361-22-005039 | Feb 14, 2022 | — |
| SC 13G/A | SERES THERAPEUTICS, INC. | 0001104659-22-022785 | Feb 14, 2022 | — |
| SC 13G | SCHEDULE 13G | 0001104659-22-018542 | Feb 10, 2022 | — |
| SC 13G/A | — | 0000315066-22-001334 | Feb 9, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-22-005322 | Feb 8, 2022 | Feb 7, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-005316 | Feb 8, 2022 | Feb 4, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-005313 | Feb 8, 2022 | Feb 4, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-005317 | Feb 8, 2022 | Feb 4, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-005315 | Feb 8, 2022 | Feb 4, 2022 |
| 3 | FORM 3 SUBMISSION | 0000899243-22-005318 | Feb 8, 2022 | Feb 7, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-005319 | Feb 8, 2022 | Feb 4, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-005320 | Feb 8, 2022 | Feb 4, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-005314 | Feb 8, 2022 | Feb 4, 2022 |
| SC 13G/A | AMENDMENT NO. 4 | 0001214659-22-001858 | Feb 4, 2022 | — |
| SC 13G/A | — | 0000834237-22-006301 | Feb 3, 2022 | — |
| 8-K | 8-K | 0001193125-21-325227 | Nov 10, 2021 | — |
| 10-Q | 10-Q | 0000950170-21-003937 | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0000950170-21-000674 | Aug 3, 2021 | Jun 30, 2021 |
| 8-K | 8-K | 0001193125-21-234005 | Aug 3, 2021 | — |
| 8-K | 8-K | 0001193125-21-221362 | Jul 22, 2021 | — |
| 8-K | 8-K | 0001193125-21-205559 | Jul 1, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-21-024994 | Jun 21, 2021 | Jun 16, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-024997 | Jun 21, 2021 | Jun 16, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-024995 | Jun 21, 2021 | Jun 16, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-024993 | Jun 21, 2021 | Jun 16, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-024990 | Jun 21, 2021 | Jun 16, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-024998 | Jun 21, 2021 | Jun 16, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-025000 | Jun 21, 2021 | Jun 16, 2021 |